BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han Q, Ma Y, Wang H, Dai Y, Chen C, Liu Y, Jing L, Sun X. Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis. J Transl Med. 2018;16:201. [PMID: 30029665 DOI: 10.1186/s12967-018-1580-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Koeberle SC, Kipp AP, Stuppner H, Koeberle A. Ferroptosis-modulating small molecules for targeting drug-resistant cancer: Challenges and opportunities in manipulating redox signaling. Med Res Rev 2023. [PMID: 36658724 DOI: 10.1002/med.21933] [Reference Citation Analysis]
2 Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol 2022;15:174. [PMID: 36482419 DOI: 10.1186/s13045-022-01392-3] [Reference Citation Analysis]
3 Shao H, Wu W, Wang P, Han T, Zhuang C. Role of Necroptosis in Central Nervous System Diseases. ACS Chem Neurosci 2022;13:3213-29. [PMID: 36373337 DOI: 10.1021/acschemneuro.2c00405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sun M, Ji X, Xie M, Chen X, Zhang B, Luo X, Feng Y, Liu D, Wang Y, Li Y, Liu B, Xia L, Huang W. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer. Front Immunol 2022;13:999084. [PMID: 36544770 DOI: 10.3389/fimmu.2022.999084] [Reference Citation Analysis]
5 He W, Chen Y, Wu L, Guo Y, You Z, Yang G. A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1018544] [Reference Citation Analysis]
6 Zhang T, Wang Y, Inuzuka H, Wei W. Necroptosis pathways in tumorigenesis. Semin Cancer Biol 2022;86:32-40. [PMID: 35908574 DOI: 10.1016/j.semcancer.2022.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Chaouhan HS, Vinod C, Mahapatra N, Yu SH, Wang IK, Chen KB, Yu TM, Li CY. Necroptosis: A Pathogenic Negotiator in Human Diseases. Int J Mol Sci 2022;23. [PMID: 36361505 DOI: 10.3390/ijms232112714] [Reference Citation Analysis]
8 El-Seedi HR, Yosri N, El-Aarag B, Mahmoud SH, Zayed A, Du M, Saeed A, Musharraf SG, El-Garawani IM, Habib MR, Tahir HE, Hegab MM, Zou X, Guo Z, Efferth T, Khalifa SAM. Chemistry and the Potential Antiviral, Anticancer, and Anti-Inflammatory Activities of Cardiotonic Steroids Derived from Toads. Molecules 2022;27:6586. [PMID: 36235123 DOI: 10.3390/molecules27196586] [Reference Citation Analysis]
9 Jia J, Li J, Zheng Q, Li D. A research update on the antitumor effects of active components of Chinese medicine ChanSu. Front Oncol 2022;12:1014637. [DOI: 10.3389/fonc.2022.1014637] [Reference Citation Analysis]
10 Ma X, Yang B, Dong H, Lin H, Wang W, Zheng M. Identification of Necroptosis-Related miRNA Signature as a Potential Predictive Biomarker for Prognosis and Immune Status in Colon Adenocarcinoma. Journal of Oncology 2022;2022:1-20. [DOI: 10.1155/2022/9413562] [Reference Citation Analysis]
11 Liang X, Cheng Z, Chen X, Li J. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis. Front Genet 2022;13:955424. [DOI: 10.3389/fgene.2022.955424] [Reference Citation Analysis]
12 Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, Chen Y, Han B. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther 2022;7:286. [PMID: 35963853 DOI: 10.1038/s41392-022-01110-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zhu Y, Ouyang Z, Du H, Wang M, Wang J, Sun H, Kong L, Xu Q, Ma H, Sun Y. New opportunities and challenges of natural products research: When target identification meets single-cell multiomics. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Wu H, Zhao X, Zhu T, Rong D, Wang Y, Leng D, Wu D. A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma. Front Genet 2022;13:856671. [DOI: 10.3389/fgene.2022.856671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 XiaYu K, GuoGang C, CanXuan L, WeiBin X. Comprehensive Characterization of Necroptosis-Related lncRNAs in Bladder Cancer Identifies a Novel Signature for Prognosis Prediction. Dis Markers 2022;2022:2360299. [PMID: 35711565 DOI: 10.1155/2022/2360299] [Reference Citation Analysis]
16 Li X, Su L, Chen W, Liu H, Zhang L, Shen Y, You J, Wang J, Zhang L, Wang D, Wen M, Wang Z, Shao Y, Chen D, Yang X. Clinical Implications of Necroptosis Genes Expression for Cancer Immunity and Prognosis: A Pan-Cancer Analysis. Front Immunol 2022;13:882216. [DOI: 10.3389/fimmu.2022.882216] [Reference Citation Analysis]
17 Gu J, He Z, Huang Y, Luan T, Chen Z, Wang J, Ding M, Bukhari I. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma. Disease Markers 2022;2022:1-21. [DOI: 10.1155/2022/5204831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Liu N, Chen HP, Yang ZM, Xia MY, Wang D, Zang LH, Liu DC. Enhancement of Dissolving Capacity and Reducing Gastric Mucosa Irritation by Complex Formation of Resibufogenin with β-Cyclodextrin or 2-Hydroxypropyl-β-cyclodextrin. Molecules 2022;27:3213. [PMID: 35630687 DOI: 10.3390/molecules27103213] [Reference Citation Analysis]
19 Tian C, Liu Y, Li Z, Zhu P, Zhao M. Mitochondria Related Cell Death Modalities and Disease. Front Cell Dev Biol 2022;10:832356. [DOI: 10.3389/fcell.2022.832356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Wu J, Ye J, Xie Q, Liu B, Liu M. Targeting Regulated Cell Death with Pharmacological Small Molecules: An Update on Autophagy-Dependent Cell Death, Ferroptosis, and Necroptosis in Cancer. J Med Chem 2022. [PMID: 35130435 DOI: 10.1021/acs.jmedchem.1c01572] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
21 Liao M, Chen R, Yang Y, He H, Xu L, Jiang Y, Guo Z, He W, Jiang H, Wang J. Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis. Acta Pharm Sin B 2022;12:678-91. [PMID: 35256939 DOI: 10.1016/j.apsb.2021.09.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
22 Liu X, Xie X, Ren Y, Shao Z, Zhang N, Li L, Ding X, Zhang L. The role of necroptosis in disease and treatment. MedComm (2020) 2021;2:730-55. [PMID: 34977874 DOI: 10.1002/mco2.108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
23 Yang Z, Lu S, Wang Y, Tang H, Wang B, Sun X, Qu J, Rao B. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer. IJGM 2022;Volume 15:555-65. [DOI: 10.2147/ijgm.s349624] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Zheng C, Tan Z. A novel identified pyroptosis-related prognostic signature of colorectal cancer. Math Biosci Eng 2021;18:8783-96. [PMID: 34814322 DOI: 10.3934/mbe.2021433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Liu Y, Chen Q, Zhu Y, Wang T, Ye L, Han L, Yao Z, Yang Z. Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis. Cell Death Discov 2021;7:210. [PMID: 34381023 DOI: 10.1038/s41420-021-00596-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
26 Zhang L, Guo W, Yu J, Li C, Li M, Chai D, Wang W, Deng W. Receptor-interacting protein in malignant digestive neoplasms. J Cancer 2021;12:4362-71. [PMID: 34093836 DOI: 10.7150/jca.57076] [Reference Citation Analysis]
27 Yang T, Jiang YX, Wu Y, Lu D, Huang R, Wang LL, Wang SQ, Guan YY, Zhang H, Luan X. Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway. Front Pharmacol 2021;12:682735. [PMID: 33995111 DOI: 10.3389/fphar.2021.682735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Li FJ, Hu JH, Ren X, Zhou CM, Liu Q, Zhang YQ. Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms. Arch Pharm (Weinheim) 2021;354:e2100060. [PMID: 33887066 DOI: 10.1002/ardp.202100060] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
29 Khan I, Yousif A, Chesnokov M, Hong L, Chefetz I. A decade of cell death studies: Breathing new life into necroptosis. Pharmacology & Therapeutics 2021;220:107717. [DOI: 10.1016/j.pharmthera.2020.107717] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]
30 Dai W, Cheng J, Leng X, Hu X, Ao Y. The potential role of necroptosis in clinical diseases (Review). Int J Mol Med 2021;47:89. [PMID: 33786617 DOI: 10.3892/ijmm.2021.4922] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
31 Wang K, Liu W, Xu Q, Gu C, Hu D. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer. Phytomedicine 2021;86:153553. [PMID: 33906076 DOI: 10.1016/j.phymed.2021.153553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Lou J, Zhou Y, Feng Z, Ma M, Yao Y, Wang Y, Deng Y, Wu Y. Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management. Front Oncol 2020;10:616952. [PMID: 33665167 DOI: 10.3389/fonc.2020.616952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
33 Lu Q, Qu Y, Ding Y, Kang X. p75NTR/proBDNF Modulates Basal Cell Carcinoma (BCC) Immune Microenvironment via Necroptosis Signaling Pathway. J Immunol Res 2021;2021:6652846. [PMID: 33604392 DOI: 10.1155/2021/6652846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Greco G, Catanzaro E, Fimognari C. Natural Products as Inducers of Non-Canonical Cell Death: A Weapon against Cancer. Cancers (Basel) 2021;13:304. [PMID: 33467668 DOI: 10.3390/cancers13020304] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
35 Yousuf M, Ahmed MT, Banerjee R. Scaffold-Based Selective ROS Generation as Viable Therapeutic Strategies Against Cancer. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects 2021. [DOI: 10.1007/978-981-15-4501-6_18-1] [Reference Citation Analysis]
36 Xue C, Gu X, Li G, Bao Z, Li L. Mitochondrial Mechanisms of Necroptosis in Liver Diseases. Int J Mol Sci 2020;22:E66. [PMID: 33374660 DOI: 10.3390/ijms22010066] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
37 Woo Y, Lee HJ, Jung YM, Jung YJ. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies. Cells 2020;9:E2709. [PMID: 33348858 DOI: 10.3390/cells9122709] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
38 Li Q, Jiang C, Wang Y, Wei M, Zheng H, Xu Y, Xu X, Jia F, Liu K, Sun G, Zang J, Mo P. RETRACTED ARTICLE: Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1. Naunyn-Schmiedeberg's Arch Pharmacol 2019;392:1477-89. [DOI: 10.1007/s00210-019-01687-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
39 Negroni A, Colantoni E, Cucchiara S, Stronati L. Necroptosis in Intestinal Inflammation and Cancer: New Concepts and Therapeutic Perspectives. Biomolecules 2020;10:E1431. [PMID: 33050394 DOI: 10.3390/biom10101431] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
40 Wang KJ, Wang KY, Zhang HZ, Meng XY, Chen JF, Wang P, Jiang JH, Ma Q. Up-Regulation of RIP3 Alleviates Prostate Cancer Progression by Activation of RIP3/MLKL Signaling Pathway and Induction of Necroptosis. Front Oncol 2020;10:1720. [PMID: 32984054 DOI: 10.3389/fonc.2020.01720] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, Meng Q, Yu X, Shi S. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol 2020;13:110. [PMID: 32778143 DOI: 10.1186/s13045-020-00946-7] [Cited by in Crossref: 328] [Cited by in F6Publishing: 357] [Article Influence: 109.3] [Reference Citation Analysis]
42 Hsu SK, Chang WT, Lin IL, Chen YF, Padalwar NB, Cheng KC, Teng YN, Wang CH, Chiu CC. The Role of Necroptosis in ROS-Mediated Cancer Therapies and Its Promising Applications. Cancers (Basel) 2020;12:E2185. [PMID: 32764483 DOI: 10.3390/cancers12082185] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
43 Huang H, Fang J, Fan X, Miyata T, Hu X, Zhang L, Zhang L, Cui Y, Liu Z, Wu X. Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses. Front Pharmacol 2020;11:1009. [PMID: 32733246 DOI: 10.3389/fphar.2020.01009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Yin H, Liu YG, Li F, Wang LQ, Zha JH, Xia YC, Yu BT, Wen DH. Resibufogenin suppresses growth and metastasis through inducing caspase-1-dependent pyroptosis via ROS-mediated NF-κB suppression in non-small cell lung cancer. Anat Rec (Hoboken) 2021;304:302-12. [PMID: 32396707 DOI: 10.1002/ar.24415] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
45 Gomes AR, Varela CL, Tavares-da-Silva EJ, Roleira FMF. Epoxide containing molecules: A good or a bad drug design approach. Eur J Med Chem 2020;201:112327. [PMID: 32526552 DOI: 10.1016/j.ejmech.2020.112327] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
46 Shen LD, Qi WH, Bai JJ, Zuo CY, Bai DL, Gao WD, Zong XL, Hao TT, Ma Y, Cao GC. Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation. Anat Rec (Hoboken) 2021;304:313-22. [PMID: 31961485 DOI: 10.1002/ar.24378] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
47 Guo Y, Liang F, Zhao F, Zhao J. Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer. Mol Cell Biochem 2020;466:103-15. [PMID: 32006291 DOI: 10.1007/s11010-020-03692-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
48 Zhan X, Wu H, Wu H, Wang R, Luo C, Gao B, Chen Z, Li Q. Metabolites from Bufo gargarizans (Cantor, 1842): A review of traditional uses, pharmacological activity, toxicity and quality control. Journal of Ethnopharmacology 2020;246:112178. [DOI: 10.1016/j.jep.2019.112178] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
49 Molnár T, Mázló A, Tslaf V, Szöllősi AG, Emri G, Koncz G. Current translational potential and underlying molecular mechanisms of necroptosis. Cell Death Dis 2019;10:860. [PMID: 31719524 DOI: 10.1038/s41419-019-2094-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 11.8] [Reference Citation Analysis]
50 Farasat M, Niazvand F, Khorsandi L. Zinc oxide nanoparticles induce necroptosis and inhibit autophagy in MCF-7 human breast cancer cells. Biologia 2020;75:161-74. [DOI: 10.2478/s11756-019-00325-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
51 Khorsandi L, Mansouri E, Rashno M, Karami MA, Ashtari A. Myricetin Loaded Solid Lipid Nanoparticles Upregulate MLKL and RIPK3 in Human Lung Adenocarcinoma. Int J Pept Res Ther 2020;26:899-910. [DOI: 10.1007/s10989-019-09895-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
52 Mbaveng AT, Bitchagno GT, Kuete V, Tane P, Efferth T. Cytotoxicity of ungeremine towards multi-factorial drug resistant cancer cells and induction of apoptosis, ferroptosis, necroptosis and autophagy. Phytomedicine 2019;60:152832. [DOI: 10.1016/j.phymed.2019.152832] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 11.8] [Reference Citation Analysis]
53 Wei WL, An YL, Li ZW, Wang YY, Ji HJ, Hou JJ, Wu WY, Guo DA. Simultaneous determination of resibufogenin and its eight metabolites in rat plasma by LC-MS/MS for metabolic profiles and pharmacokinetic study. Phytomedicine 2019;60:152971. [PMID: 31178234 DOI: 10.1016/j.phymed.2019.152971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
54 Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, Cheng H, Jin K, Ni Q, Yu X, Liu C. The role of necroptosis in cancer biology and therapy. Mol Cancer 2019;18:100. [PMID: 31122251 DOI: 10.1186/s12943-019-1029-8] [Cited by in Crossref: 305] [Cited by in F6Publishing: 334] [Article Influence: 76.3] [Reference Citation Analysis]
55 Chen C, Yao X, Xu Y, Zhang Q, Wang H, Zhao L, Wen G, Liu Y, Jing L, Sun X. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche. J Ethnopharmacol 2019;238:111878. [PMID: 30986521 DOI: 10.1016/j.jep.2019.111878] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
56 He C, Zou Z, Xia S, Xing X, Hu S, Hu Z, Li Y, Li S, Zhang H, Yang Y, Liu Y, Xu X, Liu B, Wang Y, Xu Y, Du X. Application of highly efficient and lowly toxic bufadienolides screened from toad skin in lymphatic chemotherapy for colorectal cancer through a lymphatic metastatic model. Int Immunopharmacol 2019;70:241-51. [PMID: 30851704 DOI: 10.1016/j.intimp.2019.02.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Li S, Ning LG, Lou XH, Xu GQ. Necroptosis in inflammatory bowel disease and other intestinal diseases. World J Clin Cases 2018; 6(14): 745-752 [PMID: 30510938 DOI: 10.12998/wjcc.v6.i14.745] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]